Laroprovstat for dyslipidemias

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Dec 2024: Trial started, NCT06834932
  2. 19 Feb 2025: Trial registered, NCT06834932

The trials

NCT06834932: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

State
Under way
Phase
Phase 2 and Phase 3
People
432 taking part
Started
6 Dec 2024
Primary completion
22 Feb 2027
Arms
AZD0780 +Rosuvastatin Dose 1 (Part A), AZD0780 +Rosuvastatin Dose 2 (Part A), AZD0780 (Part B Cohort 1), AZD0780+Rosuvastatin Dose 1 (Part B Cohort 2)
Results
None posted
  1. 6 Dec 2024: Trial started
  2. 19 Feb 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.